Solos Endoscopy, Inc. Has Retained Services of Experienced Medical Marketing
Firm for a 2010 Campaign
Advertising Associates International has forty-five years of experience in
medical and healthcare marketing
BOSTON, Nov. 5 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets:
SNDY) is pleased to announce that the Company has retained the services of
Advertising Associates International to manage its 2010 marketing, promotional
and advertising campaign. They offer complete media research, planning,
placement and ad tracking analysis. They have been highly regarded in the
marketing field for forty-five years and have represented numerous companies
as they achieved their marketing goals.
The AAI team includes marketing, creative and technical specialists as well as
consultants drawn from the medical, engineering and dental professions; people
with experience in business development who have helped clients build
partnerships to leverage their marketing and promotional budgets.
"We are pleased to be working with AAI once again to assist Solos Endoscopy
gaining broader worldwide exposure. I was impressed with the results we
achieved last time, and have high expectations for what our present marketing
campaign will accomplish," stated Bob Segersten, President of Solos Endoscopy,
Inc.
For more information on Advertising Associates International, visit:
www.aai-agency.com
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to
develop and market breakthrough technology, applications, medical devices and
procedural techniques for the screening, diagnosis, treatment and management
of medical conditions. Backed by technical support, Solos' sales team can help
make the right buying decisions for the hospital, surgery center, or physician
office with its catalog of FDA Approved products. Additional information is
available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that are not
historical facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected or suggested
herein due to certain risks and uncertainties including, without limitation,
ability to obtain financing and regulatory and shareholder approval for
anticipated actions.
SOURCE Solos Endoscopy, Inc.
Brian Neff, Investor Relations of Big Apple Consulting USA for Solos
Endoscopy, Inc., +1-407-389-5900
